;PMID: 3672523
;source_file_941.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..46] = [t:0..46]
;1)sentence:[e:52..172] = [t:52..172]
;2)section:[e:176..232] = [t:176..232]
;3)section:[e:236..341] = [t:236..341]
;4)sentence:[e:345..673] = [t:345..673]
;5)sentence:[e:674..940] = [t:674..940]
;6)sentence:[e:941..1159] = [t:941..1159]
;7)sentence:[e:1160..1257] = [t:1160..1257]
;8)sentence:[e:1258..1419] = [t:1258..1419]
;9)sentence:[e:1420..1579] = [t:1420..1579]
;10)sentence:[e:1580..1677] = [t:1580..1677]
;11)sentence:[e:1679..1811] = [t:1679..1811]
;12)sentence:[e:1812..1936] = [t:1812..1936]
;13)sentence:[e:1937..2017] = [t:1937..2017]
;14)sentence:[e:2018..2234] = [t:2018..2234]
;15)section:[e:2238..2282] = [t:2238..2282]

;section 0 Span:0..46
;Toxicol Appl Pharmacol. 1987 Nov;91(2):235-45.
(SEC
  (FRAG (NNP:[0..7] Toxicol) (NNP:[8..12] Appl) (NNP:[13..22] Pharmacol)
        (.:[22..23] .) (CD:[24..28] 1987) (NNP:[29..36] Nov;91-LRB-)
        (CD:[36..37] 2) (-RRB-:[37..38] -RRB-) (CD:[38..42] :235)
        (TO:[42..43] -) (CD:[43..45] 45) (.:[45..46] .)))

;sentence 1 Span:52..172
;Inhibition of central nervous system aromatase activity: a mechanism for 
;fenarimol-induced infertility in the male rat.
;[89..98]:cyp450:"aromatase"
;[126..135]:substance:"fenarimol"
(SENT
  (NP-HLN
    (NP
      (NP (NN:[52..62] Inhibition))
      (PP (IN:[63..65] of)
        (NP
          (NML (JJ:[66..73] central) (JJ:[74..81] nervous) (NN:[82..88] system))
          (NN:[89..98] aromatase) (NN:[99..107] activity))))
    (::[107..108] :)
    (NP
      (NP (DT:[109..110] a) (NN:[111..120] mechanism))
      (PP (IN:[121..124] for)
        (NP
          (ADJP (NN:[126..135] fenarimol) (HYPH:[135..136] -)
                (VBN:[136..143] induced))
          (NN:[144..155] infertility)))
      (PP-LOC (IN:[156..158] in)
        (NP (DT:[159..162] the) (JJ:[163..167] male) (NN:[168..171] rat))))
    (.:[171..172] .)))

;section 2 Span:176..232
;Hirsch KS, Weaver DE, Black LJ, Falcone JF, MacLusky NJ.
(SEC
  (FRAG (NNP:[176..182] Hirsch) (NNP:[183..185] KS) (,:[185..186] ,)
        (NNP:[187..193] Weaver) (NNP:[194..196] DE) (,:[196..197] ,)
        (NNP:[198..203] Black) (NNP:[204..206] LJ) (,:[206..207] ,)
        (NNP:[208..215] Falcone) (NNP:[216..218] JF) (,:[218..219] ,)
        (NNP:[220..228] MacLusky) (NNP:[229..232] NJ.)))

;section 3 Span:236..341
;Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, 
;Indianapolis, Indiana 46285.
(SEC
  (FRAG (NNP:[236..241] Lilly) (NNP:[242..250] Research)
        (NNP:[251..263] Laboratories) (,:[263..264] ,) (NNP:[265..268] Eli)
        (NNP:[269..274] Lilly) (VBZ:[275..278] and) (NNP:[279..286] Company)
        (NNP:[286..287] ,) (NNP:[288..293] Lilly) (NNP:[294..303] Corporate)
        (NNP:[304..310] Center) (,:[310..311] ,) (NNP:[313..325] Indianapolis)
        (,:[325..326] ,) (NNP:[327..334] Indiana) (NN:[335..340] 46285)
        (.:[340..341] .)))

;sentence 4 Span:345..673
;Fenarimol
;(alpha-(2-chlorophenyl)-alpha(4-chlorophenyl)-5-pyrimidine-methanol),  a
;pyrimidine carbinol agricultural fungicide, was previously reported to cause
;a  dose-related decrease in fertility in rats (K. S. Hirsch, E. R. Adams, D.
;G.  Hoffman, J. K. Markham, and N. V. Owen (1986), Toxicol. Appl. Pharmacol.
;86,  391-399).
;[345..354]:substance:"Fenarimol"
;[356..422]:substance:"alpha-(2-chlorophenyl)-alpha(4-chlorophenyl)-5-pyrimidi
;ne-methanol"
;[428..438]:substance:"pyrimidine"
;[439..447]:substance:"carbinol"
;[461..470]:substance:"fungicide"
(SENT
  (S
    (NP-SBJ-1
      (NP
        (NP (NN:[345..354] Fenarimol))
        (NP (-LRB-:[355..356] -LRB-)
            (NN:[356..422] alpha--LRB-2-chlorophenyl-RRB--alpha-LRB-4-chlorophenyl-RRB--5-pyrimidine-methanol)
            (-RRB-:[422..423] -RRB-)))
      (,:[423..424] ,)
      (NP (DT:[426..427] a)
        (NML (NN:[428..438] pyrimidine) (NN:[439..447] carbinol))
        (JJ:[448..460] agricultural) (NN:[461..470] fungicide)))
    (,:[470..471] ,)
    (VP (VBD:[472..475] was)
      (ADVP-TMP (RB:[476..486] previously))
      (VP (VBN:[487..495] reported)
        (S
          (NP-SBJ-1 (-NONE-:[495..495] *))
          (VP (TO:[496..498] to)
            (VP (VB:[499..504] cause)
              (NP
                (NP (DT:[505..506] a)
                  (ADJP (NN:[508..512] dose) (HYPH:[512..513] -)
                        (VBN:[513..520] related))
                  (NN:[521..529] decrease))
                (PP (IN:[530..532] in)
                  (NP (NN:[533..542] fertility))))
              (PP-LOC (IN:[543..545] in)
                (NP (NNS:[546..550] rats))))))
        (PRN (-LRB-:[551..552] -LRB-)
          (FRAG (NNP:[552..554] K.) (NNP:[555..557] S.) (NNP:[558..564] Hirsch)
                (,:[564..565] ,) (NNP:[566..568] E.) (NNP:[569..571] R.)
                (NNP:[572..577] Adams) (,:[577..578] ,) (NNP:[579..581] D.)
                (NNP:[582..584] G.) (NNP:[586..593] Hoffman) (,:[593..594] ,)
                (NNP:[595..597] J.) (NNP:[598..600] K.) (NNP:[601..608] Markham)
                (,:[608..609] ,) (CC:[610..613] and) (NNP:[614..616] N.)
                (NNP:[617..619] V.) (NNP:[620..624] Owen)
                (-LRB-:[625..626] -LRB-) (CD:[626..630] 1986)
                (-RRB-:[630..631] -RRB-) (,:[631..632] ,)
                (NNP:[633..641] Toxicol.) (NNP:[642..647] Appl.)
                (NNP:[648..658] Pharmacol.) (CD:[659..661] 86) (,:[661..662] ,)
                (CD:[664..667] 391) (HYPH:[667..668] -) (CD:[668..671] 399))
          (-RRB-:[671..672] -RRB-))))
    (.:[672..673] .)))

;sentence 5 Span:674..940
;Based on the results of a number of reproduction studies (K. S.  Hirsch, E.
;R. Adams, D. G. Hoffman, J. K. Markham, and N. V. Owen (1986),  Toxicol.
;Appl. Pharmacol. 86, 391-399), the infertility appeared to be  associated
;with an impairment of male sexual behavior.
(SENT
  (S
    (PP (VBN:[674..679] Based)
      (PP (IN:[680..682] on)
        (NP
          (NP (DT:[683..686] the) (NNS:[687..694] results))
          (PP (IN:[695..697] of)
            (NP
              (NP (DT:[698..699] a) (NN:[700..706] number))
              (PP (IN:[707..709] of)
                (NP (NN:[710..722] reproduction) (NNS:[723..730] studies)))
              (PRN (-LRB-:[731..732] -LRB-)
                (FRAG (NNP:[732..734] K.) (NNP:[735..737] S.)
                      (NNP:[739..745] Hirsch) (,:[745..746] ,)
                      (NNP:[747..749] E.) (NNP:[750..752] R.)
                      (NNP:[753..758] Adams) (,:[758..759] ,)
                      (NNP:[760..762] D.) (NNP:[763..765] G.)
                      (NNP:[766..773] Hoffman) (,:[773..774] ,)
                      (NNP:[775..777] J.) (NNP:[778..780] K.)
                      (NNP:[781..788] Markham) (,:[788..789] ,)
                      (CC:[790..793] and) (NNP:[794..796] N.)
                      (NNP:[797..799] V.) (NNP:[800..804] Owen)
                      (-LRB-:[805..806] -LRB-) (CD:[806..810] 1986)
                      (-RRB-:[810..811] -RRB-) (,:[811..812] ,)
                      (NNP:[814..822] Toxicol.) (NNP:[823..828] Appl.)
                      (NNP:[829..839] Pharmacol.) (CD:[840..842] 86)
                      (,:[842..843] ,) (CD:[844..847] 391) (HYPH:[847..848] -)
                      (CD:[848..851] 399))
                (-RRB-:[851..852] -RRB-)))))))
    (,:[852..853] ,)
    (NP-SBJ-1 (DT:[854..857] the) (NN:[858..869] infertility))
    (VP (VBD:[870..878] appeared)
      (S
        (NP-SBJ-1 (-NONE-:[878..878] *))
        (VP (TO:[879..881] to)
          (VP (VB:[882..884] be)
            (VP (VBN:[886..896] associated)
              (NP-1 (-NONE-:[896..896] *))
              (PP-CLR (IN:[897..901] with)
                (NP
                  (NP (DT:[902..904] an) (NN:[905..915] impairment))
                  (PP (IN:[916..918] of)
                    (NP (JJ:[919..923] male) (JJ:[924..930] sexual)
                        (NN:[931..939] behavior))))))))))
    (.:[939..940] .)))

;sentence 6 Span:941..1159
;When [14C]fenarimol was  administered to the dam, high concentrations of
;radioactivity were observed in  the neonatal hypothalamus, which functions in
;the development and subsequent  expression of male sexual behavior.
;[946..960]:substance:"[14C]fenarimol"
(SENT
  (S
    (SBAR-TMP
      (WHADVP-5 (WRB:[941..945] When))
      (S
        (NP-SBJ-3 (NN:[946..960] -LSB-14C-RSB-fenarimol))
        (VP (VBD:[961..964] was)
          (VP (VBN:[966..978] administered)
            (NP-3 (-NONE-:[978..978] *))
            (PP (TO:[979..981] to)
              (NP (DT:[982..985] the) (NN:[986..989] dam)))
            (ADVP-5 (-NONE-:[989..989] *T*))))))
    (,:[989..990] ,)
    (NP-SBJ-2
      (NP (JJ:[991..995] high) (NNS:[996..1010] concentrations))
      (PP (IN:[1011..1013] of)
        (NP (NN:[1014..1027] radioactivity))))
    (VP (VBD:[1028..1032] were)
      (VP (VBN:[1033..1041] observed)
        (NP-2 (-NONE-:[1041..1041] *))
        (PP-LOC (IN:[1042..1044] in)
          (NP
            (NP (DT:[1046..1049] the) (JJ:[1050..1058] neonatal)
                (NN:[1059..1071] hypothalamus))
            (,:[1071..1072] ,)
            (SBAR
              (WHNP-1 (WDT:[1073..1078] which))
              (S
                (NP-SBJ-1 (-NONE-:[1078..1078] *T*))
                (VP (VBZ:[1079..1088] functions)
                  (PP (IN:[1089..1091] in)
                    (NP
                      (NP (DT:[1092..1095] the)
                        (NML
                          (NML (NN:[1096..1107] development))
                          (CC:[1108..1111] and)
                          (NML (JJ:[1112..1122] subsequent)
                               (NN:[1124..1134] expression))))
                      (PP (IN:[1135..1137] of)
                        (NP (JJ:[1138..1142] male) (JJ:[1143..1149] sexual)
                            (NN:[1150..1158] behavior))))))))))))
    (.:[1158..1159] .)))

;sentence 7 Span:1160..1257
;In the present studies fenarimol exhibited  neither antiandrogenic nor
;antiestrogenic activities.
;[1183..1192]:substance:"fenarimol"
(SENT
  (S
    (PP-LOC (IN:[1160..1162] In)
      (NP (DT:[1163..1166] the) (JJ:[1167..1174] present)
          (NNS:[1175..1182] studies)))
    (NP-SBJ (NN:[1183..1192] fenarimol))
    (VP (VBD:[1193..1202] exhibited)
      (NP (CC:[1204..1211] neither)
        (NP (JJ:[1212..1226] antiandrogenic)
          (NML-1 (-NONE-:[1226..1226] *P*)))
        (CC:[1227..1230] nor)
        (NP (JJ:[1231..1245] antiestrogenic)
          (NML-1 (NNS:[1246..1256] activities)))))
    (.:[1256..1257] .)))

;sentence 8 Span:1258..1419
;The compound did, however,  prevent the increase in nuclear estrogen
;receptors in the brain which normally  occurs in the male during the early
;postnatal period.
;[1262..1270]:substance:"compound"
;[1318..1336]:substance:"estrogen receptors"
(SENT
  (S
    (NP-SBJ (DT:[1258..1261] The) (NN:[1262..1270] compound))
    (VP (VBD:[1271..1274] did) (,:[1274..1275] ,)
      (ADVP (RB:[1276..1283] however))
      (,:[1283..1284] ,)
      (VP (VB:[1286..1293] prevent)
        (NP
          (NP
            (NP (DT:[1294..1297] the) (NN:[1298..1306] increase))
            (PP (IN:[1307..1309] in)
              (NP (JJ:[1310..1317] nuclear)
                 (NN:[1318..1326] estrogen) (NNS:[1327..1336] receptors)))
            (PP-LOC (IN:[1337..1339] in)
              (NP (DT:[1340..1343] the) (NN:[1344..1349] brain))))
          (SBAR
            (WHNP-1 (WDT:[1350..1355] which))
            (S
              (NP-SBJ-1 (-NONE-:[1355..1355] *T*))
              (ADVP-MNR (RB:[1356..1364] normally))
              (VP (VBZ:[1366..1372] occurs)
                (PP-LOC (IN:[1373..1375] in)
                  (NP (DT:[1376..1379] the) (NN:[1380..1384] male)))
                (PP-TMP (IN:[1385..1391] during)
                  (NP (DT:[1392..1395] the)
                    (ADJP (JJ:[1396..1401] early) (JJ:[1402..1411] postnatal))
                    (NN:[1412..1418] period)))))))))
    (.:[1418..1419] .)))

;sentence 9 Span:1420..1579
;These results suggested  that fenarimol might be acting to inhibit estrogen
;biosynthesis (via the  aromatase enzyme complex) within the central nervous
;system.
;[1450..1459]:substance:"fenarimol"
;[1487..1495]:substance:"estrogen"
;[1519..1543]:cyp450:"aromatase enzyme complex"
(SENT
  (S
    (NP-SBJ (DT:[1420..1425] These) (NNS:[1426..1433] results))
    (VP (VBD:[1434..1443] suggested)
      (SBAR (IN:[1445..1449] that)
        (S
          (NP-SBJ-1 (NN:[1450..1459] fenarimol))
          (VP (MD:[1460..1465] might)
            (VP (VB:[1466..1468] be)
              (VP (VBG:[1469..1475] acting)
                (S
                  (NP-SBJ-1 (-NONE-:[1475..1475] *))
                  (VP (TO:[1476..1478] to)
                    (VP (VB:[1479..1486] inhibit)
                      (NP (NN:[1487..1495] estrogen)
                          (NN:[1496..1508] biosynthesis))
                      (PRN (-LRB-:[1509..1510] -LRB-)
                        (PP (IN:[1510..1513] via)
                          (NP (DT:[1514..1517] the)
                             (NN:[1519..1528] aromatase)
                             (NN:[1529..1535] enzyme) (NN:[1536..1543] complex)))
                        (-RRB-:[1543..1544] -RRB-))
                      (PP-LOC (IN:[1545..1551] within)
                        (NP (DT:[1552..1555] the) (JJ:[1556..1563] central)
                            (JJ:[1564..1571] nervous) (NN:[1572..1578] system))))))))))))
    (.:[1578..1579] .)))

;sentence 10 Span:1580..1677
;[3H]Testosterone  was administered to neonatal rats, and the tritiated
;metabolites were isolated.
;[1580..1596]:substance:"[3H]Testosterone"
;[1651..1662]:substance:"metabolites"
(SENT
  (S
    (S
      (NP-SBJ-2 (NN:[1580..1596] -LSB-3H-RSB-Testosterone))
      (VP (VBD:[1598..1601] was)
        (VP (VBN:[1602..1614] administered)
          (NP-2 (-NONE-:[1614..1614] *))
          (PP (TO:[1615..1617] to)
            (NP (JJ:[1618..1626] neonatal) (NNS:[1627..1631] rats))))))
    (,:[1631..1632] ,) (CC:[1633..1636] and)
    (S
      (NP-SBJ-1 (DT:[1637..1640] the) (VBN:[1641..1650] tritiated)
                (NNS:[1651..1662] metabolites))
      (VP (VBD:[1663..1667] were)
        (VP (VBN:[1668..1676] isolated)
          (NP-1 (-NONE-:[1676..1676] *)))))
    (.:[1676..1677] .)))

;sentence 11 Span:1679..1811
;Testosterone and dihydrotestosterone (17 beta-hydroxy-5
;alpha-androstan-3-one)  concentrations were similar in all treatment groups.
;[1679..1691]:substance:"Testosterone"
;[1696..1715]:substance:"dihydrotestosterone"
;[1717..1756]:substance:"17 beta-hydroxy-5 alpha-androstan-3-one"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1679..1691] Testosterone)
        (NML-1 (-NONE-:[1691..1691] *P*)))
      (CC:[1692..1695] and)
      (NP
        (NML
          (NML (NN:[1696..1715] dihydrotestosterone))
          (NML (-LRB-:[1716..1717] -LRB-)
             (CD:[1717..1719] 17) (NN:[1720..1734] beta-hydroxy-5)
             (NN:[1735..1756] alpha-androstan-3-one)
            (-RRB-:[1756..1757] -RRB-)))
        (NML-1 (NNS:[1759..1773] concentrations))))
    (VP (VBD:[1774..1778] were)
      (ADJP-PRD (JJ:[1779..1786] similar))
      (PP-LOC (IN:[1787..1789] in)
        (NP (DT:[1790..1793] all) (NN:[1794..1803] treatment)
            (NNS:[1804..1810] groups))))
    (.:[1810..1811] .)))

;sentence 12 Span:1812..1936
;Tritiated estrogens were  detected in the brain cell nuclei from control
;neonates but not in neonates  exposed to fenarimol.
;[1822..1831]:substance:"estrogens"
;[1926..1935]:substance:"fenarimol"
(SENT
  (S
    (NP-SBJ-3 (VBN:[1812..1821] Tritiated) (NNS:[1822..1831] estrogens))
    (VP (VBD:[1832..1836] were)
      (VP
        (VP (VBN:[1838..1846] detected)
          (NP-3 (-NONE-:[1846..1846] *))
          (PP-LOC=2 (IN:[1847..1849] in)
            (NP
              (NP (DT:[1850..1853] the) (NN:[1854..1859] brain)
                  (NN:[1860..1864] cell) (NNS:[1865..1871] nuclei))
              (PP (IN:[1872..1876] from)
                (NP (NN:[1877..1884] control) (NNS:[1885..1893] neonates))))))
        (CC:[1894..1897] but)
        (VP (RB:[1898..1901] not)
          (PP-LOC=2 (IN:[1902..1904] in)
            (NP
              (NP (NNS:[1905..1913] neonates))
              (VP (VBN:[1915..1922] exposed)
                (NP (-NONE-:[1922..1922] *))
                (PP-CLR (TO:[1923..1925] to)
                  (NP (NN:[1926..1935] fenarimol)))))))))
    (.:[1935..1936] .)))

;sentence 13 Span:1937..2017
;Fenarimol was also observed to inhibit rat ovarian  aromatase activity in
;vitro.
;[1937..1946]:substance:"Fenarimol"
;[1989..1998]:cyp450:"aromatase"
(SENT
  (S
    (NP-SBJ-1 (NN:[1937..1946] Fenarimol))
    (VP (VBD:[1947..1950] was)
      (ADVP (RB:[1951..1955] also))
      (VP (VBN:[1956..1964] observed)
        (S
          (NP-SBJ-1 (-NONE-:[1964..1964] *))
          (VP (TO:[1965..1967] to)
            (VP (VB:[1968..1975] inhibit)
              (NP (NN:[1976..1979] rat) (JJ:[1980..1987] ovarian)
                  (NN:[1989..1998] aromatase) (NN:[1999..2007] activity))
              (ADVP (FW:[2008..2010] in) (FW:[2011..2016] vitro)))))))
    (.:[2016..2017] .)))

;sentence 14 Span:2018..2234
;These data indicate that the decrease in male  sexual behavior and the
;infertility associated with exposure to fenarimol were,  most likely, due to
;inhibition of aromatase activity within the central nervous  system.
;[2129..2138]:substance:"fenarimol"
;[2180..2189]:cyp450:"aromatase"
(SENT
  (S
    (NP-SBJ (DT:[2018..2023] These) (NNS:[2024..2028] data))
    (VP (VBP:[2029..2037] indicate)
      (SBAR (IN:[2038..2042] that)
        (S
          (NP-SBJ
            (NP
              (NP (DT:[2043..2046] the) (NN:[2047..2055] decrease))
              (PP (IN:[2056..2058] in)
                (NP (JJ:[2059..2063] male) (JJ:[2065..2071] sexual)
                    (NN:[2072..2080] behavior))))
            (CC:[2081..2084] and)
            (NP
              (NP (DT:[2085..2088] the) (NN:[2089..2100] infertility))
              (VP (VBN:[2101..2111] associated)
                (NP (-NONE-:[2111..2111] *))
                (PP-CLR (IN:[2112..2116] with)
                  (NP
                    (NP (NN:[2117..2125] exposure))
                    (PP (TO:[2126..2128] to)
                      (NP (NN:[2129..2138] fenarimol))))))))
          (VP (VBD:[2139..2143] were) (,:[2143..2144] ,)
            (ADVP (RBS:[2146..2150] most) (RB:[2151..2157] likely))
            (,:[2157..2158] ,)
            (PP-PRD (IN:[2159..2162] due)
              (PP (TO:[2163..2165] to)
                (NP
                  (NP (NN:[2166..2176] inhibition))
                  (PP (IN:[2177..2179] of)
                    (NP (NN:[2180..2189] aromatase) (NN:[2190..2198] activity)))
                  (PP (IN:[2199..2205] within)
                    (NP (DT:[2206..2209] the) (JJ:[2210..2217] central)
                        (JJ:[2218..2225] nervous) (NN:[2227..2233] system))))))))))
    (.:[2233..2234] .)))

;section 15 Span:2238..2282
;PMID: 3672523 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2238..2242] PMID) (::[2242..2243] :) (CD:[2244..2251] 3672523)
        (IN:[2252..2253] -LSB-) (NNP:[2253..2259] PubMed) (HYPH:[2260..2261] -)
        (JJ:[2262..2269] indexed) (IN:[2270..2273] for)
        (NNP:[2274..2282] MEDLINE-RSB-)))
